The Next Industrial Revolution May Begin Inside a Living Cell

A new Breakthroughs™ PSA featuring Prolific Machines introduces photomolecular biology — an emerging platform using light to guide cellular behavior.

EMERYVILLE, CA, UNITED STATES, October 26, 2026 /EINPresswire.com/ — Prolific Machines is helping define a new frontier in biomanufacturing through its pioneering work in photomolecular biology — an emerging field that uses light to help guide how living cells behave.

At the center of the company’s work is a powerful idea: if cells are already capable of producing some of the most complex biological products on earth, then the future of manufacturing may depend on learning how to communicate with those cells more precisely. Traditional biomanufacturing often relies on static genetic programming, chemical triggers, and complex process controls to influence when and how cells produce biological materials. Prolific Machines is developing a different approach: using light as a dynamic control system to regulate cellular activity with greater precision.

The company’s platform is designed to harness light-responsive biological systems to help control gene expression inside living cells. In practical terms, light can act like a dial — helping determine when specific cellular processes turn on, how strongly they activate, and how production can be adjusted throughout the culture process.

This represents a potentially significant shift for biologics manufacturing. Many next-generation medicines and biological products are difficult to produce consistently, efficiently, and at scale. By using light to guide cellular behavior, Prolific Machines is working to give scientists and manufacturers a new level of control over biological production.

The company has already demonstrated important progress toward scale. Prolific Machines announced the completion of a 200-liter optogenetic bioproduction run, described by the company as the world’s largest demonstration of optogenetics to date and the first demonstration of optogenetics in a stainless-steel bioreactor. The milestone was completed at the company’s Emeryville pilot production facility and supports the broader goal of bringing light-controlled biomanufacturing into practical, commercial-scale applications.

For the public, the importance of this work is not limited to the laboratory. If biological production can become more precise, more programmable, and more scalable, the benefits could eventually reach across multiple fields — from complex biologic medicines and advanced therapeutics to nutritional ingredients, sustainable manufacturing, and other biological materials.

For patients, the long-term promise is clearer access to biological products that may otherwise be too difficult, inconsistent, or costly to manufacture. For biopharmaceutical developers, the potential value lies in improving manufacturability, yield, quality control, and process flexibility. For CDMOs, advanced nutrition companies, and life-science partners, light-controlled biomanufacturing may offer a new toolset for producing biological products with greater reliability and control.

The professional impact may be equally important. Biomanufacturing is no longer only a back-end production challenge. It is becoming a strategic bottleneck for the future of medicine. As therapeutics become more complex, the ability to manufacture them efficiently may determine which discoveries can actually reach patients.

That is why Prolific Machines’ work stands out. The company is not simply improving a single manufacturing step. It is helping introduce a new control language for biology — one in which light can become an instruction, a signal, and a mechanism for guiding living systems.

To help make this highly technical advancement understandable to broader national and international audiences, Prolific Machines is being featured in the Breakthroughs™ Public Service Announcement series in a segment titled “The Code of Life: Photomolecular Biology.”

The PSA is designed to translate the significance of light-controlled biomanufacturing into a compelling public-interest message: the next industrial revolution may not begin with steel, steam, or silicon, but inside a living cell — guided by light. The segment introduces photomolecular biology as an emerging platform with implications for medicine, nutrition, biotechnology, and the future of biological manufacturing. Rather than functioning as a commercial, the PSA frames the subject as a larger public-interest story about how scientific advances behind the scenes can ultimately affect lives, industries, and the future of care.

As Prolific Machines continues to advance its platform, the company’s work is drawing attention from across biotechnology, pharmaceutical manufacturing, advanced nutrition, and life-science innovation. The broader message is simple: biology already knows how to build extraordinary things. The next breakthrough may be learning how to guide it with the precision modern manufacturing demands.

About Prolific Machines
Prolific Machines is advancing light-controlled biomanufacturing through its photomolecular biology platform, which combines optogenetic tools, illumination systems, process development, and advanced bioprocess control to help guide cellular behavior. The company is focused on enabling more precise and scalable production of complex biologics and other biological products for biopharma and related life-science partners.

About Breakthroughs™
Breakthroughs™ is a public-interest PSA series created to help broader audiences understand important advancements in science, medicine, technology, sustainability, infrastructure, and human progress through high-end PSA storytelling, national and international distribution, and targeted professional outreach. The series focuses on emerging and under-recognized innovations that have the potential to improve lives, reshape industries, and solve meaningful real-world challenges.

Dan Johnson
OMDprm
+1 646-350-2503
djohnson@omdprm.com

:60 Preview of the Prolific Machines PSA introducing photomolecular biology